EN | ES | קריירה במגו-אפק
EN | ES | קריירה במגו-אפק
For patients living with chronic lymphedema, venous insufficiency, nonhealing wounds, and other peripheral circulatory diseases
For patients living with chronic lymphedema, venous insufficiency, nonhealing wounds, and other peripheral circulatory diseases
Pneumatic Compression systems and garments with patented overlapping technology for maximum treatment.
Helping patients all over the world for over 40 years to better manage lymphedema and venous insufficiency
Pneumatic Compression systems and garments with patented overlapping technology for maximum treatment.
Helping patients all over the world for over 40 years to better manage lymphedema and venous insufficiency
Intermittent Pneumatic Compression (IPC) systems for prevention of deep vein thrombosis in patients who are at risk. The systems apply external gradient circumferential compression to the legs or to the soles of the feet, in a gentle pressure wave that mimics the action of natural walking. This increases blood flow and prevents venous stasis.
Intermittent Pneumatic Compression (IPC) systems for prevention of deep vein thrombosis in patients who are at risk. The systems apply external gradient circumferential compression to the legs or to the soles of the feet, in a gentle pressure wave that mimics the action of natural walking. This increases blood flow and prevents venous stasis.
Bringing advanced medical technology to the aesthetic world with advanced
treatment for cellulite reduction, body shaping and relaxation
with state-of-the-art Smart Technology™ that adapts to each client’s body shape, for effective and individualized treatment.
Bringing advanced medical technology to the aesthetic world with advanced
treatment for cellulite reduction, body shaping and relaxation
with state-of-the-art Smart Technology™ that adapts to each client’s body shape, for effective and individualized treatment.
Mego Afek’s quality management system is ISO 13485:2016 certified, in accordance with CFR 820 Quality System Regulation, European Medical Directives 93/42/EEC, 2007/47/EC. Clearances and marketing approvals include FDA, CE Mark, MHLW (Japan), ANVISA (Brazil).
Some systems may not be cleared for sale in all markets. Please contact us for information on country-specific sales clearances and approvals for individual products.